Clinical trials
Spondylitis, Ankylosing trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chengdu PLA General Hospital | 2 |
| Charite University, Berlin, Germany | 1 |
| China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | 1 |
| Nanfang Hospital, Southern Medical University | 1 |
| Peking Union Medical College Hospital | 1 |
| Qilu Hospital of Shandong University | 1 |
| Shandong University | 1 |
| Shanghai University of Traditional Chinese Medicine | 1 |
| Shanghai Zhongshan Hospital | 1 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Spondylitis, Ankylosing | 15 |
| Spondylarthritis | 4 |
| Arthritis | 2 |
| Spondylarthropathies | 2 |
| Ankylosis | 1 |
| Axial Spondyloarthritis | 1 |
| Bone Diseases | 1 |
| Drug-Related Side Effects and Adverse Reactions | 1 |
| Low Back Pain | 1 |
| Musculoskeletal Diseases | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.